Belkahia A, Bouzouita H
Sem Hop. 1978 Jun;54(17-20):621-4.
Tiapride was studied in 60 patients with ENT affections. The dosage was 1 to 2 ampoules IM a day for 7 to 10 days, followed by a half a tablet 3 to 4 times a day for 2 weeks to 2 months. Results were excellent or good for 16 out of 20 cases of essential headache, 6 out of 6 cases of Barré Liéou's syndrome, 7 out 8 cases of sinus pain, 6 out of 8 cases of Méniè's disease, and 6 out of 6 cases of facial paralysis "a frigore". In 7 cases of post-concussion syndrome, excellent results were observed in all the patients, on headache. Vertigo was reduced in intensity. The effects was moderate or nil on tinnitus and deafness due to Ménières syndrome, as well as in 2 casls of facial neuralgia. Tolorance was excellent as, in these 60 patients, only 2 cases of dry mouth and 1 case of vomiting in a diabetic were reported.
对60例耳鼻喉科疾病患者进行了硫必利研究。剂量为每日1至2安瓿，肌肉注射，共7至10天，随后每日3至4次，每次半片，持续2周至2个月。20例原发性头痛患者中16例效果极佳或良好；6例巴雷-利厄综合征患者中6例效果良好；8例鼻窦疼痛患者中7例效果良好；8例梅尼埃病患者中6例效果良好；6例“受寒性”面瘫患者中6例效果良好。在7例脑震荡后综合征患者中，所有患者的头痛症状均有极佳效果，眩晕强度降低。对梅尼埃综合征引起的耳鸣和耳聋以及2例面部神经痛的效果中等或无效。耐受性良好，在这60例患者中，仅报告了2例口干和1例糖尿病患者呕吐。
